News | June 07, 2022
MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
Five patient-first principles to provide the highest standard of healthcare
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
Subscribe To Our Newsletter & Stay Updated
